Related Experiment Video

Updated: Jan 6, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K

Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere

Woo Jong Cho1, Kaeum Choi2, Kyunghwa Han1

  • 1Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.

Journal of Neuro-Oncology
|December 1, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
GliomaMagnetic resonance imagingNot elsewhere classifiedSurvivalWorld Health Organization

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.7K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.1K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.7K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.4K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

Articles linked to this work by shared authors, journal, and citation graph.

Simpson Grading and Risk of Recurrence in 4074 Meningioma Patients With Gross Total Resection.

Neurosurgery·2026

Increased risk of early recurrence after gross-total resection in males with a WHO grade II meningioma: the impact of sex on recurrence and death in 5441 meningioma patients.

Journal of neurosurgery·2026

Reduced-dose Radiotherapy without Chemotherapy for Intracranial Germinomas: Results from an Asian Multicenter Study.

Neuro-oncology·2026

Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems.

Journal of neuro-oncology·2026

Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.

Experimental & molecular medicine·2026

BKCa channel deletion modulates the DNA damage response to electron ultra-high dose rate irradiation in glioblastoma cells.

Journal of neuro-oncology·2026

Radiation-induced cranial meningiomas are associated with earlier relapse: a propensity score-matched cohort study.

Journal of neuro-oncology·2026

Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments).

Journal of neuro-oncology·2026

Patient-derived tissue cultures complement neurospheres for preclinical evaluation of AAV-mediated gene delivery in glioblastoma.

Journal of neuro-oncology·2026

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis.

Journal of neuro-oncology·2026

Intracranial germ cell tumors: an underrecognized diagnostic consideration in adults with sellar/suprasellar lesions.

Journal of neuro-oncology·2026

Characterisation of the Novel HLA-DQA1*04:01:11 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQB1*03:612 Allele by Sequencing-Based Typing.

HLA·2026

Identification of a New HLA-DRB5 Allele in a Chinese Han Individual, HLA-DRB5*01:01:17.

HLA·2026

The Novel HLA-DPB1*1903:01 Allele Was Likely Generated by a Recombination Event.

HLA·2026

Characterisation of the Novel HLA-C*16:01:53 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-F*01:37 Allele Using PolyseqOne Sequencing.

HLA·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us